CT KUB in Renal Cysts
Validation of CT KUB in Assesment of Renal Cysts
1 other identifier
observational
200
0 countries
N/A
Brief Summary
- 1.Primary (main):
- 2.Secondary (subsidiary):
- 3.Assess interobserver agreement in CT KUB interpretation among radiologists with varying levels of expertise.
- 4.Identify limitations and pitfalls in the use of non-contrast CT KUB for characterizing renal cysts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2025
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 10, 2025
CompletedFirst Posted
Study publicly available on registry
September 23, 2025
CompletedStudy Start
First participant enrolled
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 31, 2027
September 23, 2025
September 1, 2025
1.5 years
September 10, 2025
September 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Validiation of CT KUB results in assesment of Renal Cystic Lesions prospectively in comparison to Ultrasonographic as in terms of Sensitivity and Specificity regarding evalution of Cystic lesion complexity according to Bosniak Classification
CT KUB cyst evaluation Qualitatively as Gross Picture and Quantitavely using Hausfield units then Abdomianl ultrasound , otherwise Bosniak I Renal cysts will undergo further assessment contrast-enhanced CT then Follow Up or Histopathology Data will be captured on a pre-piloted electronic case report form with de-identified study codes. Statistical analysis (sensitivity, specificity, PPV, NPV, accuracy, ROC/AUC) and inter-/intra-observer agreement (κ/ICC) will be conducted using SPSS/R/Stata. Quality assurance will follow institutional scanner QA logs, a priori reader calibration, and an audit-trailed database.
From Time of CT KUB referal till accurate diagnosis of Cystic lesion up to 24 weeks
Interventions
All Patients will undergo CT KUB cyst evaluation Qualitatively regarding Gross Picture in Imaging and Quantitavely using Hausfield units then patients will undergo Abdomianl ultrasound
Eligibility Criteria
Patients with Renal Cysts referred to CT KUB for any indication
You may qualify if:
- Patients referred for CT KUB with detectable Renal cysts
You may not qualify if:
- Patients with known renal tumors.
- Inadequate imaging quality: CT KUB with severe motion/streak artifact or incomplete anatomical coverage preventing lesion assessment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Forookhi, A., Bicchetti, M., Lucciola, S. et al. The thin line that made the difference: a case report on a Bosniak IIF renal cystic mass treated with cyst decortication. Egypt J Radiol Nucl Med 53, 115 (2022). https://doi.org/10.1186/s43055-022-00791-3
BACKGROUNDSmith AD, Remer EM, Cox KL, Lieber ML, Allen BC, Shah SN, Herts BR. Bosniak category IIF and III cystic renal lesions: outcomes and associations. Radiology. 2012 Jan;262(1):152-60. doi: 10.1148/radiol.11110888. Epub 2011 Nov 21.
PMID: 22106359BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident Doctor
Study Record Dates
First Submitted
September 10, 2025
First Posted
September 23, 2025
Study Start
October 1, 2025
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
October 31, 2027
Last Updated
September 23, 2025
Record last verified: 2025-09